FDA.reportPublic FDA data

Application 204723

Type
ANDA
Sponsor
AKORN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDESOLUTION/DROPS;OPHTHALMICEQ 0.2% BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17478-305OlopatadineOlopatadine HydrochlorideAkornANDACurrent
17478-305OlopatadineOlopatadine HydrochlorideAkorn, Inc.ANDACurrent
17478-305OlopatadineOlopatadine HydrochlorideAkornANDACurrent
17478-305OlopatadineOlopatadine HydrochlorideAkorn, Inc.ANDACurrent
17478-305OlopatadineOlopatadine HydrochlorideAkorn, Inc.ANDACurrent
17478-312OlopatadineOlopatadine HydrochlorideAkornANDACurrent
17478-312OlopatadineOlopatadine HydrochlorideAkorn, Inc.ANDACurrent
50090-3489OlopatadineOlopatadine HydrochlorideA-S Medication SolutionsANDACurrent
50090-3489OlopatadineOlopatadine HydrochlorideA-S Medication SolutionsANDACurrent